Role of selective leptin resistance in diet-induced obesity hypertension

被引:265
作者
Rahmouni, K
Morgan, DA
Morgan, GM
Mark, AL
Haynes, WG
机构
[1] Univ Iowa, Cardiovasc Res Ctr, Hypertens Genet Specialized Ctr Res, Iowa City, IA 52242 USA
[2] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA
关键词
D O I
10.2337/diabetes.54.7.2012
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Leptin is an adipocyte-derived hormone that plays a key role in the regulation of body weight through its actions on appetite and metabolism. Leptin also increases sympathetic nerve activity (SNA) and blood pressure. We tested the hypothesis that diet-induced obesity is associated with resistance to the metabolic actions of leptin but preservation of its renal SNA and arterial pressure effects, leading to hypertension. Mice were fed a high-fat diet for 10 weeks to induce moderate obesity. The decrease in food intake and body weight induced by intraperitoneal or intracerebroventricular leptin was significantly attenuated in the obese mice. Regional SNA responses to leptin were differentially altered in diet-induced obese mice. Renal SNA response to leptin was preserved, whereas lumbar and brown adipose tissue SNA responses were attenuated in obese mice. Radiotelemetric arterial pressure was similar to 10 mmHg higher in obese mice. Furthermore, the increase in arterial pressure in response to long-term (12 days) leptin treatment was preserved in obese mice. Thus, mice with diet-induced obesity exhibit circulating hyperleptinemia and resistance to the metabolic actions of leptin. However, there is preservation of the renal sympathetic and arterial pressure responses to leptin, which represent a potential mechanism for the adverse cardiovascular consequences of obesity.
引用
收藏
页码:2012 / 2018
页数:7
相关论文
共 30 条
[1]   Pathophysiological role of leptin in obesity-related hypertension [J].
Aizawa-Abe, M ;
Ogawa, Y ;
Masuzaki, H ;
Ebihara, K ;
Satoh, N ;
Iwai, H ;
Matsuoka, N ;
Hayashi, T ;
Hosoda, K ;
Inoue, G ;
Yoshimasa, Y ;
Nakao, K .
JOURNAL OF CLINICAL INVESTIGATION, 2000, 105 (09) :1243-1252
[2]   Sympathetic neural activation in visceral obesity [J].
Alvarez, GE ;
Beske, SD ;
Ballard, TP ;
Davy, KP .
CIRCULATION, 2002, 106 (20) :2533-2536
[3]   Hypertension and obesity [J].
Aneja, A ;
El-Atat, F ;
McFarlane, S ;
Sowers, JR .
RECENT PROGRESS IN HORMONE RESEARCH, VOL 59: CARDIOVASCULAR ENDOCRINOLOGY & OBESITY, 2004, 59 :169-205
[4]   High fat feeding is associated with increased blood pressure, sympathetic nerve activity and hypothalamic mu opioid receptors [J].
Barnes, MJ ;
Lapanowski, K ;
Conley, A ;
Rafols, JA ;
Jen, KLC ;
Dunbar, JC .
BRAIN RESEARCH BULLETIN, 2003, 61 (05) :511-519
[5]   Chronic cardiovascular and renal actions of leptin - Role of adrenergic activity [J].
Carlyle, M ;
Jones, OB ;
Kuo, JJ ;
Hall, JE .
HYPERTENSION, 2002, 39 (02) :496-501
[6]   Decreased cerebrospinal-fluid/serum leptin ratio in obesity: A possible mechanism for leptin resistance [J].
Caro, JF ;
Kolaczynski, JW ;
Nyce, MR ;
Ohannesian, JP ;
Opentanova, I ;
Goldman, WH ;
Lynn, RB ;
Zhang, PL ;
Sinha, MK ;
Considine, RV .
LANCET, 1996, 348 (9021) :159-161
[7]   Serum immunoreactive leptin concentrations in normal-weight and obese humans [J].
Considine, RV ;
Sinha, MK ;
Heiman, ML ;
Kriauciunas, A ;
Stephens, TW ;
Nyce, MR ;
Ohannesian, JP ;
Marco, CC ;
McKee, LJ ;
Bauer, TL ;
Caro, JF .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (05) :292-295
[8]   The concept of selective leptin resistance - Evidence from agouti yellow obese mice [J].
Correia, MLG ;
Haynes, WG ;
Rahmouni, K ;
Morgan, DA ;
Sivitz, WI ;
Mark, AL .
DIABETES, 2002, 51 (02) :439-442
[9]   Attenuation of leptin-mediated effects by monosodium glutamate-induced arcuate nucleus damage [J].
Dawson, R ;
Pelleymounter, MA ;
Millard, WJ ;
Liu, S ;
Eppler, B .
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 1997, 273 (01) :E202-E206
[10]   The sympathetic nervous system and hypertension - Recent developments [J].
DiBona, GF .
HYPERTENSION, 2004, 43 (02) :147-150